4//SEC Filing
Cantley Lewis Clayton Jr. 4
Accession 0001209191-17-064704
CIK 0001439222other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 4:23 PM ET
Size
24.0 KB
Accession
0001209191-17-064704
Insider Transaction Report
Form 4
Cantley Lewis Clayton Jr.
Director10% Owner
Transactions
- Sale
Common stock
2017-12-06$58.95/sh−254$14,973→ 80,638 total(indirect: See footnote) - Sale
Common stock
2017-12-06$60.01/sh−204$12,242→ 80,394 total - Sale
Common stock
2017-12-07$60.45/sh−631$38,144→ 79,515 total(indirect: See footnote) - Sale
Common stock
2017-12-06$58.95/sh−253$14,914→ 80,598 total - Sale
Common stock
2017-12-06$60.01/sh−204$12,242→ 80,434 total(indirect: See footnote) - Sale
Common stock
2017-12-07$59.68/sh−288$17,188→ 80,146 total(indirect: See footnote) - Sale
Common stock
2017-12-06$57.90/sh−542$31,382→ 80,892 total(indirect: See footnote) - Sale
Common stock
2017-12-06$57.90/sh−543$31,440→ 80,851 total - Sale
Common stock
2017-12-07$59.68/sh−288$17,188→ 80,106 total - Sale
Common stock
2017-12-07$60.45/sh−631$38,144→ 79,475 total
Holdings
- 20,803(indirect: See footnote)
Common stock
- 20,803(indirect: See footnote)
Common stock
Footnotes (9)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $57.48 to $58.30. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]Shares held by Vicki Lee Sato, who is the reporting person's spouse.
- [F4]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.58 to $59.21. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F5]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.62 to $60.55. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F6]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.99 to $59.95. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F7]The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $60.00 to $60.79. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F8]Shares held by grantor retained annuity trusts for the benefit of the reporting person and his two children, of which the reporting person is trustee and sole annuitant.
- [F9]Shares held by grantor retained annuity trusts for the benefit of the reporting person's spouse and their two children, of which the reporting person's spouse is trustee and sole annuitant.
Documents
Issuer
AGIOS PHARMACEUTICALS INC
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001581950
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 4:23 PM ET
- Size
- 24.0 KB